Loading...
XOSL
MEDI
, Last price  
Name

Medistim ASA

Chart & performance

D1W1MN
XOSL:MEDI chart
P/E
—
P/S
—
EPS
8.68
Vol. 1Y
—
Shs. 5Y
0.04%
Rev. 5Y
14.46%
Div Yld LY
—
Div Yld TTM
—
Revenues
700m
+24.38%
97,599,000126,853,000140,290,000156,870,000156,801,000159,619,000181,974,000190,333,000214,251,000249,970,000262,673,000296,054,000323,010,000356,914,000356,208,000417,817,000486,262,000521,109,000562,599,000699,767,000
Net income
159m
+53.33%
028,393,00013,537,00027,874,00018,657,00015,488,00030,247,00026,536,00031,245,00040,422,00039,098,00047,574,00057,055,00070,306,00069,387,00090,900,000113,973,000103,823,000103,832,000159,210,000
CFO
187m
+32.16%
17,312,00020,802,00026,761,00032,783,00037,270,00024,662,00026,250,00026,044,00048,939,00044,656,00030,472,00060,103,00055,792,00080,380,00074,134,000128,138,000113,491,000113,189,000141,561,000187,084,000
Dividend
May 07, 20268 /sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which are designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation; ultrasound imaging probes; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical equipment. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway.

Key people

President, Chief Executive Officer · since 2009
Bjorn M. Wiggen
Deputy Chairman of the Board
Thomas Kure Jakobsen
Chief Financial Officer · since 2001
Mike Farbelow
President of Medistim USA, Inc. · since 2014
Ole Jorgen Robsrud
Managing Director Medistim Norge AS
Haege Johanne Krogh Wetterhus
Vice President Marketing
Anders Lillebo
Vice President Manufacturing · since 2004
Tone Ann Veiteberg
Vice President Regulatory Affairs & Quality Assurance
Roger Reino Morberg
Vice President Sales · since 2010
Siri Furst
Director · since 2013
Director · since 2014
Lars Ronn
Director
IPO date
May 28, 2004
Employees
132
Domiciled in
NO
Incorporated in
NO
Headquarters & legal address
Økernveien 94
Oslo, 03 0579
NO
Address
Okernveien 94
Oslo, 03 0579
NO

Valuation

Title
NOK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT